[1] 王恒,蔡庆和,涂华,等.前入路肝切除术在原发性肝癌手术中的应用价值分析.肝脏,2019,24:1021-1024. [2] Dendle C,Gan PY,Polkinghorne KR,et al.Natural Killer cell function predicts severe infection in kidney transplant recipients.Am J Transplant,2018,19:166-177. [3] Zheng MJ,Sun H,Tian Z.Natural killer cells in liver diseases.Front Med,2018,12:269-279. [4] Male V,Stegmann KA,Easom NJ,et al.Natural Killer Cells in Liver Disease.Semin Liver Dis,2017,37:198-209. [5] 王姜琳,杨慧健,于修文,等.原发性肝癌患者免疫细胞变化及其与HBV-DNA、HBeAg和肿瘤大小的关系.检验医学与临床,2019,16:1659-1661. [6] Peng Y,Qi X,Guo X.Child–Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis.Medicine,2016,95:e2877. [7] 赵睿,董晨,周为,等.人体免疫衰老与肿瘤及感染的关系研究进展.中华医学杂志,2019,99:1278-1280. [8] Wellenstein MD,Visser KED.Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.Immunity,2018,48:399-416. [9] 贾户亮,钦伦秀.肝细胞癌术后复发的预测与预防策略.中华肝脏病杂志,2016,24:330-334. [10] Dauffenbach LM,Sia GC,Zheng J,et al.Abstract 1669:Multiplex immunohistochemical staining of PD-L1, PD-1, CD3, CD4, CD8, CD68, FoxP3, and Ki-67 and image analysis of tumor and invasive margin in human FFPE NSCLC tissue.Cancer Res,2017,77:1669-1669. [11] 高卫勤,段升强,范益民,等.不同级别脑胶质瘤患者围术期细胞免疫水平变化及其与术后颅内感染关系的研究.肿瘤研究与临床,2019,31:437-441. [12] 吕松琴,黄山,李晓非,等.昆明地区健康成年人外周血T淋巴细胞亚群参考区间调查.临床检验杂志,2017,35:310-313. [13] 任海龙,邵东燕,李琦,等.NK细胞应用于肿瘤免疫治疗的研究进展.现代免疫学,2017,37:61-65. [14] 张帆,邸泰霖,韩克松.NK、Th17和Treg细胞水平对结直肠癌患者术后复发预测价值的分析.中国中西医结合外科杂志,2019,25:448-452. [15] Xia Y,Zhang Q.Negatively regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway.Oncotarget,2017,8:37783-37795. [16] 李冬冬,楚社录.肺癌根治术式对老年肺癌病人围术期T淋巴细胞亚群及肿瘤微转移的影响.安徽医药,2019,23:976-980. [17] 周启明,吴沛宏.T淋巴细胞亚群及NK细胞变化与原发性肝癌预后的关系.介入放射学杂志,2005,14:635-637. [18] 梁新强,刘海洲,利基林,等.原发性肝癌和慢性乙型肝炎患者外周血T淋巴细胞亚群和NK细胞水平分析.广西医科大学学报,2013,30:407-408. |